Results 251 to 260 of about 276,548 (307)
Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba +5 more
wiley +1 more source
In silico framework for designing and validating a multi-stage subunit vaccine against Tuberculosis using reverse vaccinology approach. [PDF]
Liaqat A +4 more
europepmc +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source
Conformational stability and domain-specific structural features of tumor autoantigens regulate autoantibody epitope propensity. [PDF]
Miyamoto A +13 more
europepmc +1 more source
A multi-epitope-based DNA vaccine confers cross-protection against influenza A H1N1 and H3N2 viruses. [PDF]
Barkhordari K +9 more
europepmc +1 more source
epiTOol: a browser-based HLA epitope (mis)matching application for small to large cohorts. [PDF]
Lehmann C +3 more
europepmc +1 more source

